Mythos Arrives with Guardrails—and a Hefty Price Tag
Anthropic has officially released a version of its Mythos large language model that it claims is safe for public use, ending months of speculation about whether the system would ever see the light of day. According to reports from the BBC, New York Times, and CNBC, the new model—reportedly named Mythos Safe—comes with additional guardrails and user limitations, and carries a price tag roughly double that of Anthropic's previous flagship model, Claude.
The launch marks a dramatic reversal for the company, which had previously stated that Mythos was too dangerous to release due to its advanced capabilities. Anthropic executives had warned that the model could be misused for generating disinformation, automating cyberattacks, or producing highly convincing fake content. Yet now, with a modified version in hand, the company is offering access to select enterprise customers—at a premium.
“We believe Mythos Safe provides the benefits of frontier AI while mitigating the most significant risks,” an Anthropic spokesperson said in a statement. “Our safety-first approach means restricting access to vetted organizations that agree to strict usage policies.”
The Safety Narrative Under Scrutiny
Not everyone is buying the safety narrative. Critics and industry observers have pointed out that the sudden availability of a “safe” version—after months of dramatic warnings—looks like a calculated marketing move. The Guardian quoted several AI researchers who suspect the company deliberately amplified safety concerns to generate hype, drive up perceived value, and justify the higher price point.
“Anthropic has played a very clever game,” said one AI ethics researcher who asked not to be named. “By declaring Mythos too risky for release, they created an aura of exclusivity and power. Now they’re selling it as a safer, curated product—at twice the cost.”
The pricing strategy is notable: Anthropic’s Claude 3 Opus, its previous top-tier model, cost $15 per million input tokens and $75 per million output tokens. While exact pricing for Mythos Safe has not been publicly detailed, multiple sources confirm it is roughly double those rates. That would place it competitively against OpenAI’s most expensive offerings, but with the added premium of “safety” baked in.
Selective Access as a Strategic Play
The launch aligns with a broader trend among frontier AI labs: using selective access as a business and credibility strategy. Axios reported that this approach has become common among labs like OpenAI, Google DeepMind, and Anthropic, who ration access to their most powerful models behind waitlists, enterprise agreements, and usage caps. The message is that these models are not just tools but powerful, even dangerous, technologies that require stewardship.
For Anthropic, which has positioned itself as the safety-first alternative to OpenAI, the Mythos saga reinforces that brand identity. By releasing a “safe” version, the company can claim it walked the walk—while still monetizing the underlying technology. However, the two-month gap between the initial “too dangerous” announcement and the commercial release has raised eyebrows.
The timeline is short for genuine safety research. “If the model truly posed existential risks, you’d expect months or years of red-teaming, not a quick retooling and a price hike,” said a machine learning engineer who has worked on AI alignment. “It suggests the safety concerns were always more about PR than actual danger.”
Enterprise Adoption and Regulatory Implications
Early adopters include financial institutions and defense contractors, according to sources familiar with the matter. These organizations are willing to pay the premium for exclusive access and the promise of enhanced safety. “If Anthropic can really deliver a model that is both powerful and safe, the price is worth it,” said a chief data officer at a Fortune 500 company who is trialing Mythos Safe.
The development also has regulatory implications. Lawmakers in the US and EU have been debating how to classify and regulate frontier models. Anthropic’s move could set a precedent: instead of hard regulation, the market might self-regulate via pricing and access tiers. “Anthropic is essentially creating a safety premium,” said a tech policy analyst. “If other labs follow, we could see a two-tier AI market—one for safe, expensive models, and another for free or cheap, less safe ones.”
Looking Ahead: The Mythos Precedent
The Mythos release is unlikely to be the last time an AI lab uses the “too dangerous to release” card as a marketing lever. As competition intensifies, labs need differentiation beyond raw performance. Safety branding—and the associated premium pricing—could become the new normal.
However, the strategy carries risks. If users find that Mythos Safe is still capable of harmful outputs despite the guardrails, or if competitors release equally capable models at lower prices, Anthropic’s credibility could suffer. For now, the industry is watching closely. The first independent audits of Mythos Safe are expected within weeks, and their findings will determine whether the model lives up to its billing—or whether the safety narrative was just another play for profit.
Comments